Roche signs neu­rode­gen­er­a­tion pact with stealthy biotech, pri­mar­i­ly fo­cus­ing on ALS

Ear­li­er this week, Roche part­nered with a lit­tle-known biotech in a new neu­ro­log­i­cal dis­ease col­lab­o­ra­tion aim­ing to treat ALS and po­ten­tial­ly oth­er de­bil­i­tat­ing ill­ness­es. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER